Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
139.5 USD | -0.36% | +1.01% | +18.08% |
Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.08% | 7.99B | |
+9.77% | 15.13B | |
-25.48% | 11.28B | |
-4.03% | 6.62B | |
+34.56% | 1.96B | |
+27.24% | 983M | |
+9.62% | 919M | |
+9.54% | 765M | |
-4.86% | 669M | |
-20.25% | 406M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- Stifel Nicolaus Raises Crane's Price Target to $150 From $135, Maintains Buy Rating